ID

26579

Beschrijving

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00811135

Link

https://clinicaltrials.gov/show/NCT00811135

Trefwoorden

  1. 19-10-17 19-10-17 -
  2. 22-10-17 22-10-17 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

19 oktober 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT00811135

Eligibility Breast Cancer NCT00811135

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Beschrijving

Adult | Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
breast cancer with measurable locally recurrent or metastatic lesions;
Beschrijving

Breast Carcinoma | Measurable lesion recurrent locally | Measurable lesion metastatic

Datatype

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C2945760
UMLS CUI [2,3]
C1517927
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C1522484
candidate for chemotherapy;
Beschrijving

Indication Chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0392920
her2-positive disease;
Beschrijving

Disease HER2/Neu Positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348909
ecog ps of <=2.
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous anticancer therapy for metastatic breast cancer;
Beschrijving

Cancer treatment Secondary malignant neoplasm of female breast

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0346993
previous radiotherapy for metastatic breast cancer (except for adjuvant radiotherapy >=6 months before enrollment);
Beschrijving

Therapeutic radiology procedure Secondary malignant neoplasm of female breast | Exception Adjuvant Radiotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0346993
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0242939
chronic daily treatment with corticosteroids (>=10mg/day), aspirin (>325 mg/day) or clopidogrel (>75mg/day);
Beschrijving

Adrenal Cortex Hormones U/day | Aspirin U/day | Clopidogrel U/day

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0456683
UMLS CUI [3,1]
C0070166
UMLS CUI [3,2]
C0456683
other primary tumor within last 5 years, except for adequately treated cervical cancer in situ, squamous or basal cell skin cancer;
Beschrijving

Primary tumor | Exception Carcinoma in situ of uterine cervix Treated | Exception Squamous cell carcinoma of skin Treated | Exception Basal cell carcinoma Treated

Datatype

boolean

Alias
UMLS CUI [1]
C0677930
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
uncontrolled hypertension or significant cardiovascular disease.
Beschrijving

Uncontrolled hypertension | Cardiovascular Diseases

Datatype

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0007222

Similar models

Eligibility Breast Cancer NCT00811135

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast Carcinoma | Measurable lesion recurrent locally | Measurable lesion metastatic
Item
breast cancer with measurable locally recurrent or metastatic lesions;
boolean
C0678222 (UMLS CUI [1])
C1513041 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
Indication Chemotherapy
Item
candidate for chemotherapy;
boolean
C3146298 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Disease HER2/Neu Positive
Item
her2-positive disease;
boolean
C0012634 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
ECOG performance status
Item
ecog ps of <=2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cancer treatment Secondary malignant neoplasm of female breast
Item
previous anticancer therapy for metastatic breast cancer;
boolean
C0920425 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
Therapeutic radiology procedure Secondary malignant neoplasm of female breast | Exception Adjuvant Radiotherapy
Item
previous radiotherapy for metastatic breast cancer (except for adjuvant radiotherapy >=6 months before enrollment);
boolean
C1522449 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0242939 (UMLS CUI [2,2])
Adrenal Cortex Hormones U/day | Aspirin U/day | Clopidogrel U/day
Item
chronic daily treatment with corticosteroids (>=10mg/day), aspirin (>325 mg/day) or clopidogrel (>75mg/day);
boolean
C0001617 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0070166 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
Primary tumor | Exception Carcinoma in situ of uterine cervix Treated | Exception Squamous cell carcinoma of skin Treated | Exception Basal cell carcinoma Treated
Item
other primary tumor within last 5 years, except for adequately treated cervical cancer in situ, squamous or basal cell skin cancer;
boolean
C0677930 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Uncontrolled hypertension | Cardiovascular Diseases
Item
uncontrolled hypertension or significant cardiovascular disease.
boolean
C1868885 (UMLS CUI [1])
C0007222 (UMLS CUI [2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial